Augmented reality treadmill training for people with Parkinson's disease
Augmented Reality Treadmill Training in Patients With Parkinson's Disease: a Randomized Controlled Study
This study tests whether using augmented reality and dual task training on a treadmill can help people with Parkinson's disease improve their walking and reduce falls.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 50 (estimated) |
| Ages | 35 Years to 99 Years |
| Sex | All |
| Sponsor | Klinik Valens Academic / other |
| Locations | 1 site (Valens, Saint Gallen) |
| Trial ID | NCT04108741 on ClinicalTrials.gov |
What this trial studies
This study compares three different methods of treadmill training for patients with Parkinson's disease to evaluate the effectiveness of augmented reality (AR) and dual task (DT) training. Participants will undergo training over three weeks, with assessments focusing on falls, walking, freezing, and attention over a three-month period. The study is designed as a double-blinded randomized controlled trial to ensure unbiased results during regular neurorehabilitation.
Who should consider this trial
Good fit: Ideal candidates include individuals with Parkinson's disease who have experienced at least one fall in the past three months and have gait disorders.
Not a fit: Patients with dementia or those unable to participate in treadmill therapy due to physical limitations will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve gait stability and reduce falls in patients with Parkinson's disease.
How similar studies have performed: While augmented reality applications in rehabilitation are emerging, this specific approach has not been widely tested, making it a novel investigation.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Informed Consent as documented by signature * Parkinson´s disease without dementia and hallucination * at least one fall within the past 3 months or postural instability * Gait disorder * Hoehn and Yahr stages II-IV * able to perform the treadmill therapy during a study Exclusion Criteria: * Contraindications to treadmill therapy (e.g. hip fracture) * Dementia as defined by an Montreal cognitive assessment (MOCA) \< 20
Where this trial is running
Valens, Saint Gallen
- Department of Neurology — Valens, Saint Gallen, Switzerland (Recruiting)
Study contacts
- Principal investigator: Veit Mylius, Prof. Dr. — Department of Neurology, Kliniken Valens
- Study coordinator: Veit Mylius, Prof. Dr.
- Email: veit.mylius@kliniken-valens.ch
- Phone: 0041813031406
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.